Immediate allergic reactions to cephalosporins and penicillins and their cross-reactivity in children

被引:81
作者
Atanaskovic-Markovic, M
Velickovic, TC
Gavrovic-Jankulovic, M
Vuckovic, O
Nestorovic, B
机构
[1] Univ Childrens Hosp, Dept Allergol & Pulmonol, Belgrade, Serbia Monteneg
[2] Univ Belgrade, Fac Chem, Dept Biochem, Belgrade 11001, Serbia Monteneg
[3] Inst Immunol & Virol, Dept Allergol & Immunol, Belgrade, Serbia Monteneg
关键词
betalactams; cephalosporins; children; cross-reactivity; drug allergy; immediate allergic reaction; penicillins;
D O I
10.1111/j.1399-3038.2005.00280.x
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Penicillins and cephalosporins are the most important betalactams inducing IgE-mediated reactions. The safety of administering cephalosporins to penicillin-allergic children is a particular problem, because cephalosporin allergenic determinants have not been properly identified. A study was undertaken to evaluate the frequency of anaphylactic reactions to cephalosporins and penicillins and their cross-reactivity in a pediatric population. A prospective survey was conducted in a group of 1170 children with suspected immediate allergic reactions to cephalosporins and/or penicillins, which were examined during a period of 8 yr. In vivo (skin tests and challenges) and in vitro tests (for specific IgE) were performed with standard concentration of penicillins and cephalosporins. When 1170 children with a clinical history of allergy to penicillins and/or cephalosporins were tested in vivo for immediate hypersensitivity to betalactams, 58.3% cases overall were found to be skin or challenge test positive. Among them, 94.4% patients were positive to penicillins and 35.3% to cephalosporins. The frequency of positive reactions in the in vivo testing was in the range from 36.4% to 88.1% for penicillins and from 0.3% to 29.2% for cephalosporins. However, 31.5% of the penicillin allergic children cross-reacted to some cephalosporin. If a child was allergic to a cephalosporin, the frequency of positive reactions to penicillin was 84.2%. The cross-reactivity between cephalosporins and penicillins varied between 0.3% and 23.9%. The cross-reactivity among different generations of cephalosporins varied between 0% and 68.8%, being the highest for first and second-generation cephalosporins and 0% for third generation cephalosporins. The frequency of immediate allergic reactions to cephalosporins is considerably lower compared to penicillins, and the degree of cross-reactivity between cephalosporins and penicillins depends on the generation of cephalosporins, being higher with earlier generation cephalosporins. The cross-reactivity among cephalosporins is lower compared to cross-reactivity between penicillins and cephalosporins.
引用
收藏
页码:341 / 347
页数:7
相关论文
共 43 条
  • [1] Adkinson N. F. Jr., 1998, Clinical and Experimental Allergy, V28, P37
  • [2] Anderson John A., 1994, Current Opinion in Pediatrics, V6, P656, DOI 10.1097/00008480-199412000-00008
  • [3] ANNE S, 1995, ANN ALLERG ASTHMA IM, V74, P167
  • [4] Type-I hypersensitivity to ceftriaxone and cross-reactivity with cefalexin and ampicillin
    Atanaskovic-Markovic, M
    Gavrovic-Jankulovic, M
    Velickovic, TC
    Vuckovic, O
    Todoric, D
    [J]. ALLERGY, 2003, 58 (06) : 537 - 538
  • [5] ALLERGIC REACTIONS TO BETA-LACTAMS - STUDIES IN A GROUP OF PATIENTS ALLERGIC TO PENICILLIN AND EVALUATION OF CROSS-REACTIVITY WITH CEPHALOSPORIN
    AUDICANA, M
    BERNAOLA, G
    URRUTIA, I
    ECHECHIPIA, S
    GASTAMINZA, G
    MUNOZ, D
    FERNANDEZ, E
    DECORRES, LF
    [J]. ALLERGY, 1994, 49 (02) : 108 - 113
  • [6] Baldo BA, 1999, CLIN EXP ALLERGY, V29, P744
  • [7] Baldo BA, 2000, ALLERGY CLIN IMMUNOL, V12, P206
  • [8] Long persistence of IgE antibody to cefaclor
    Bernardini, R
    Novembre, E
    Lombardi, E
    Pucci, N
    Rossi, ME
    Vierucci, A
    [J]. ALLERGY, 2000, 55 (10) : 984 - 985
  • [9] Birkebaek N H, 1992, Ugeskr Laeger, V154, P331
  • [10] Natural evolution of skin test sensitivity in patients allergic to β-lactam antibiotics
    Blanca, M
    Torres, MJ
    García, JJ
    Romano, A
    Mayorga, C
    de Ramon, E
    Vega, JM
    Miranda, A
    Juarez, C
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 103 (05) : 918 - 924